| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |